SARS-CoV-2 JN.1 variant evasion of IGHV3-53/3-66 B cell germlines,Science Immunology

当前位置： X-MOL 学术 › Sci. Immunol › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

SARS-CoV-2 JN.1 variant evasion of IGHV3-53/3-66 B cell germlines
Science Immunology ( IF 17.6 ) Pub Date : 2024-08-09 , DOI: 10.1126/sciimmunol.adp9279
Ida Paciello ₁ , Giuseppe Maccari ₂ , Giulio Pierleoni _{1,

3} , Federica Perrone _{1,

3} , Giulia Realini ₁ , Marco Troisi ₁ , Gabriele Anichini ₄ , Maria Grazia Cusi ₄ , Rino Rappuoli _{3,

5} , Emanuele Andreano ₁

Affiliation

The severe acute respiratory syndrome coronavirus 2 variant JN.1 recently emerged as the dominant variant despite having only one amino acid change on the spike (S) protein receptor binding domain (RBD) compared with the ancestral BA.2.86, which never represented more than 5% of global variants. To define at the molecular level the JN.1 ability to spread globally, we interrogated a panel of 899 neutralizing human monoclonal antibodies. Our data show that the single leucine-455–to–serine mutation in the JN.1 spike protein RBD unleashed the global spread of JN.1, likely occurring by elimination of more than 70% of the neutralizing antibodies mediated by IGHV3-53/3-66 germlines. However, the resilience of class 3 antibodies with low neutralization potency but strong Fc functions may explain the absence of JN.1 severe disease.

更新日期：2024-08-09

点击分享查看原文

点击收藏

阅读更多本刊新发论文